Rutgers University Study of the Genetics of Blood Cancers

Starting soon

Conditions studied: Blood Cancers, Blood Cancer, Leukemia, Lymphoma, Myeloma, Hematologic Cancer, Hematologic Malignancies, Hematologic Neoplasm, Hematologic Tumors

In brief

The goal of this study is to enroll at least 10,000 participants nationally including affecteds and unaffecteds via online study portal, collect surveys online and a saliva sample through the mail, sequence DNA, and conduct genetic analyses to identify novel variants and further study known variants associated with leukemia, lymphoma, myeloma and other blood cancers.

Key facts

Study ID

NCT07714044

Run by

Rutgers, The State University of New Jersey

People needed

10000

Starts

2026-08-01

Expected to finish

2029-08-01

Last updated by the study team

2026-07-20

Who can join

Age: 18 and older, up to 110. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• age 18 years or older
• currently living in the United States
• have access to the internet and a computer, laptop, tablet or smartphone
• willing to provide written informed consent for participation
• willing to provide DNA via a saliva sample using a collection kit mailed to your home
• willing to complete a survey with questions about health related to the study of blood cancer.

You may not qualify if…

• Not able to meet or fulfill any of the inclusion criteria

Where it is running

• Rutgers University — Piscataway, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.